Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

7 Dividend Aristocrats to Buy for Long-Term Income

By Alex Sirois, InvestorPlace Contributor
These dividend aristocrats are the best stocks to buy for long-term income generation and lower portfolio risk.

Why Is Bluebird Bio (BLUE) Stock Up 17% Today?

By Josh Enomoto, InvestorPlace Contributor
Bluebird Bio received a major lift from JPMorgan Chase regarding its gene-editing therapeutic, sending BLUE stock flying.

3 High-Yield Cannabis Stocks for Income Investors

By Ian Cooper, InvestorPlace Contributor
Cannabis stocks may appear to have gone up in smoke. But don’t count them out. It’s only a matter of time before they see higher highs.

Why Is ENDRA Life Sciences (NDRA) Stock Down 16% Today?

By William White, InvestorPlace Writer
ENDRA Life Sciences (NDRA) stock is sliding lower on Friday after revealing details of its public offering for 862,500 shares.

Why Is Hillstream BioPharma (HILS) Stock Down 57% Today?

By William White, InvestorPlace Writer
Hillstream BioPharma (HILS) stock is taking a beating on Friday after the company revealed plans for a public offering of its shares.

The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy

By Chris Markoch, InvestorPlace Contributor
Here are three biotech companies with promising innovations that could provide catalysts for their respective stocks in 2023

3 Telemedicine Stocks to Watch as Healthcare Goes Digital

By Muslim Farooque, InvestorPlace Contributor
The telemedicine stocks discussed in the article offer incredible upside ahead in the fast-evolving telehealth sector

7 Small-Cap Biotech Stocks with Massive Potential

By Josh Enomoto, InvestorPlace Contributor
Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.

3 Long-Term Stocks to Buy and Hold Forever

By Bret Kenwell, InvestorPlace Contributor
When it comes to stocks to buy and hold forever, investors have to make sure that the business will be around for the long term.

3 Stocks to Buy to Benefit from the Booming Pet Care Industry

By Ian Bezek, InvestorPlace Contributor
Pet stocks may have lost their momentum over the past year, but these three picks are soon due for a recovery.

GSK Stock: A Value Trap or a Hidden Gem?

By Samuel O'Brient, InvestorPlace Reporter
GSK, formerly known as GlaxoSmithKline, is struggling after a complicated earnings season. Here's why GSK stock is still a buy.

LLY Stock Alert: Mounjaro Takes Eli Lilly to the Next Level

By William White, InvestorPlace Writer
Eli Lilly (LLY) stock is climbing higher on Thursday thanks to a boost from Mounjaro during its earnings report for Q1 2023.

Why Is Baudax Bio (BXRX) Stock Down 52% Today?

By William White, InvestorPlace Writer
Baudax Bio (BXRX) stock is falling hard on Thursday after the pharmaceutical company announced a $4 million public stock offering.

Why Is Evelo Biosciences (EVLO) Stock Up 78% Today?

By William White, InvestorPlace Writer
Evelo Biosciences (EVLO) stock is on the rise Thursday after the company said it's shifting focus toward extracellular vesicle development.

7 Biotech Stocks With Huge Return Potential for Long-Term Investors

By Josh Enomoto, InvestorPlace Contributor
Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers.

7 Dividend Stocks to Buy and Hold for the Next Decade

By Alex Sirois, InvestorPlace Contributor
This list includes strong dividend stocks to buy and hold for a decade plus that appeal to more risk-averse and passive investors.

The 3 Most Promising Healthcare Tech Stocks for April 2023

By Alex Sirois, InvestorPlace Contributor
The best healthcare tech stocks provide investors with impressive upside potential, while promising to improve the healthcare sector.

7 Stocks That Are Strong Buys on the Heels of Impressive Earnings

By Chris Lau, InvestorPlace Contributor
Investors looking for strong buys in this market may want to consider companies that reported strong earnings recently.

Why Is ZyVersa Therapeutics (ZVSA) Stock Down 46% Today?

By William White, InvestorPlace Writer
ZyVersa Therapeutics (ZVSA) stock is sliding lower on Wednesday following a couple of announcements from the biopharmaceutical company.
Load More Articles